Literature DB >> 26530859

miR-124 suppresses the migration and invasion of glioma cells in vitro via Capn4.

Jia-Jun Cai1, Zeng-Xin Qi1, Ling-Chao Chen1, Yu Yao1, Yan Gong2, Ying Mao1.   

Abstract

miR-124 and Capn4 are aberrantly expressed in glioblastoma multiforme (GBM) tissues. In the present study, we investigated miR-124 and Capn4 expression in GBM tissue specimens. The role of miR-124 and Capn4 in the migration and invasion of glioma cells in vitro was also examined. miR-124 and Capn4 expression in 20 GBM and 6 control brain specimens was examined using RT-qPCR and immuno-blotting. Data from The Cancer Genome Atlas were retrieved. Candidate mRNA target sites of miR-124 were predicted using TargetScan/microRNA and binding was examined using dual luciferase reporter assays. The U87 and U251 cells were transfected with scrambled microRNA, miR-124 mimics and/or pLenti-Capn4 prior to wound‑healing and Transwell invasion assays. Proteins involved in the epithelial-mesenchymal transition were examined using immunoblotting. The results showed that miR-124 was significantly downregulated in GBM tissues. Immunoblotting showed a marked upregulation of Capn4 expression in GBM tissues. The Spearman's correlation analysis revealed a negative association between miR-124 expression and Capn4 protein levels. TargetScan/microRNA predicted the miR-124 binding site in the nucleotide 440-446 region within the Capn4 3'-UTR, which was confirmed by luciferase assays. Wound‑healing and Transwell invasion assays demonstrated that Capn4 downregulation or miR-124 mimics suppressed the migration and invasion of glioma cells. Capn4 downregulation or miR-124 mimics reduced the level of phospho-FAK and MMP2, vimentin and N-cadherin in U87 cells. In conclusion, miR-124 was found to suppress the migration and invasion of glioma cells in vitro via Capn4.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26530859     DOI: 10.3892/or.2015.4355

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  23 in total

1.  Rap2B promotes cell proliferation, migration and invasion in prostate cancer.

Authors:  Jiehui Di; Huan Cao; Juangjuan Tang; Zheng Lu; Keyu Gao; Zhesi Zhu; Junnian Zheng
Journal:  Med Oncol       Date:  2016-05-06       Impact factor: 3.064

2.  MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells.

Authors:  Baoyuan Shi; Yandan Wang; Fengfang Yin
Journal:  Cancer Biol Ther       Date:  2017-08-31       Impact factor: 4.742

3.  MicroRNA-124 suppresses tumor cell proliferation and invasion by targeting CD164 signaling pathway in non-small cell lung cancer.

Authors:  Jing Lin; Kai Xu; Jun Wei; Amy B Heimberger; Jack A Roth; Lin Ji
Journal:  J Gene Ther       Date:  2016-02-13

Review 4.  Aberrant miRNAs Regulate the Biological Hallmarks of Glioblastoma.

Authors:  Wanli Yu; Sai Liang; Chunzhi Zhang
Journal:  Neuromolecular Med       Date:  2018-09-04       Impact factor: 3.843

Review 5.  Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review).

Authors:  Roberto Gambari; Eleonora Brognara; Demetrios A Spandidos; Enrica Fabbri
Journal:  Int J Oncol       Date:  2016-05-04       Impact factor: 5.650

6.  Sulforaphane improves chemotherapy efficacy by targeting cancer stem cell-like properties via the miR-124/IL-6R/STAT3 axis.

Authors:  Xingxing Wang; Yuan Li; Yi Dai; Qinqiang Liu; Shilong Ning; Jiao Liu; Zhaoxia Shen; Dongmei Zhu; Fei Jiang; Jianping Zhang; Zhong Li
Journal:  Sci Rep       Date:  2016-11-08       Impact factor: 4.379

7.  miR-124 suppresses proliferation and invasion of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway by targeting Capn4.

Authors:  Haili Hu; Guanghui Wang; Congying Li
Journal:  Onco Targets Ther       Date:  2017-05-23       Impact factor: 4.147

Review 8.  Tumor Suppressive Effects of miR-124 and Its Function in Neuronal Development.

Authors:  Rikako Sanuki; Tomonori Yamamura
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

9.  Functional genomics analyses of RNA-binding proteins reveal the splicing regulator SNRPB as an oncogenic candidate in glioblastoma.

Authors:  Bruna R Correa; Patricia Rosa de Araujo; Mei Qiao; Suzanne C Burns; Chen Chen; Richard Schlegel; Seema Agarwal; Pedro A F Galante; Luiz O F Penalva
Journal:  Genome Biol       Date:  2016-06-10       Impact factor: 13.583

10.  MicroRNA-124-3p regulates cell proliferation, invasion, apoptosis, and bioenergetics by targeting PIM1 in astrocytoma.

Authors:  Danni Deng; Lei Wang; Yao Chen; Bowen Li; Lian Xue; Naiyuan Shao; Qiang Wang; Xiwei Xia; Yilin Yang; Feng Zhi
Journal:  Cancer Sci       Date:  2016-06-21       Impact factor: 6.518

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.